continuing education, physical therapy, occupational therapy - rehabedge.com

Printer Friendly Copy

Pharmacology for Physical Therapy:: 30 Contact Hour Bundle Pack

HomeCEUConnection.com


Format(s):   Home-study
Discipline(s):   Physical Therapy / Occupational Therapy
Contact Hours:   30
Registration Fee:   $390


Objectives
At the end of Module 1, the professional will be able to:
1. Identify the two main areas of pharmacology. 2. List the four phases of an investigational new drug. 3. Identify the barriers to development of new drugs faced by drug researchers. 4. Identify the five schedules that classify controlled substances. 5. Explain the difference between specificity and selectivity, as it is relates to drug receptor interactions. 6. Define partial agonist. 7. Describe the four main ways drugs cross the cell membranes. 8. Describe the difference between enteral and parenteral drug administration. 9. Identify the most common ways in which drugs are excreted from the body. 10. Describe the affect exercise has on pharmacokinetics. 11. Identify the alphabetical classification of adverse drug effects. 12. Identify the four types of drug allergies. 13. Describe the functions of the autonomic nervous system, and its specific innervations. 14. Explain the therapeutic concerns with direct-acting and in-direct acting muscarinic agents. 15. Identify the forms of, effects, and indications for the use of epinephrine. 16. Identify the two types of hypertension. 17. Identify therapeutic concerns with diuretics, beta-blockers, alpha blockers, direct vasodilators, calcium channel blockers, ACE inhibitors and ACE receptor blockers. 18. List the three major recognized forms of angina. 19. Identify therapeutic concerns with antithrombotic drugs, and lipid lowering agents. 20. Identify the pharmacological management of deep vein thrombosis, pulmonary embolism, peripheral arterial disease, unstable angina and myocardial infarction. 21. Identify drugs used in the treatment and management of congestive heart failure. 22. Identify the four classes and therapeutic concerns of antiarrhythmic drugs. 23. Identify the stimulants that inflame the bronchi in bronchial asthma. 24. Describe the two theories regarding the pathogenesis of exercise-induced asthma. 25. Identify the therapeutic concerns with drugs for respiratory disorders. 26. Identify drugs used in the treatment and management of bronchial asthma, chronic obstructive pulmonary disease and cystic fibrosis. 27. Describe the three main phases of digestion. 28. Identify the drugs used in the treatment and management of acid related diseases, nausea and vomiting, diarrhea, constipation and irritable bowel syndrome. 29. Identify therapeutic concerns with gastrointestinal agents. At the end of Module 2, the professional will be able to: 1. Identify the therapeutic concerns with anesthesia and local anesthetic agents. 2. Identify the drugs to be stopped, continued, or started preoperatively. 3. Demonstrate knowledge of the two mechanisms involved with pain production. 4. Identify the adverse and beneficial effects of aspirin. 5. Identify therapeutic concerns with nonsteroidal anti-inflammatory drugs. 6. Describe the role prostaglandins play in inflammation. 7. Identify drugs used in the treatment of rheumatoid arthritis, gout, systemic lupus erythematosus and osteoarthritis. 8. Identify the therapeutic concerns with drugs used for the treatment of rheumatoid arthritis, gout, systemic lupus erythematosus and osteoarthritis. 9. Identify the therapeutic concerns with hypopituitarism and hypothyroidism. 10. Identify the diseases, drug regimen and adverse effects for pituitary, thyroid and adrenal cortex dysfunction. 11. Identify the factors that influence the loss of bone mass in osteoporosis. 12. Identify the drugs used, pathogenesis, prevention and treatment of osteoporosis. 13. Identify therapeutic concerns regarding anti-osteoporosis agents. 14. Lists factors that may help improve glycemic response to exercise and avoid hypoglycemia in diabetic patients. 15. Identify the drugs used, pathophysiology and symptoms of diabetes. 16. Identify three methods, the FDA has approved for testing glucose levels. 17. Identify the effects of insulin on carbohydrate, fat, and protein metabolism in the liver, muscle, and adipose tissue. 18. Demonstrate knowledge of the acceptable blood glucose levels for diabetics at various times of the day. 19. Identify the adverse effects of insulin. 20. Define depression. 21. Identify the mechanism of action, indication for use and side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants for patients with depression and anxiety. 22. Demonstrate knowledge of guidelines for use of antidepressants and therapeutic concerns. 23. Identify clinical considerations with benzodiazepines in patients with anxiety. 24. Demonstrate knowledge of the etiology, pathogenesis and drug treatment for schizophrenia and bipolar disorder. 25. Identify the therapeutic concerns with typical antipsychotic agents, atypical antipsychotic agents and with drugs for bipolar disorder.
At the end of tModule 3, the professional will be able to:
1. Explain the difference between partial seizures and generalized seizures. 2. Identify factors associated with seizure activity. 3. Identify the main mechanism of action for the following antiepileptic drugs: barbiturates, phenytoin, carbamazepine, valproic acid, ethosuximide, lamotrigine, gabapentin, levetiracetam and oxcarbazepine. 4. Identify the general approach to the management of epilepsy and therapeutic concerns. 5. Identify the main mechanism of action for the following ADHD drugs: stimulant therapy, antidepressants, alpha-2 noradrenergic agonist and atomoxetine. 6. Identify therapeutic concerns with drugs for ADHD. 7. Define spasticity. 8. Identify the efficacy and adverse effects of antispasticity medications. 9. Identify the mechanism of action, site of injection, onset and duration for ethyl alcohol, phenol and botulinum toxin when treating spasticity locally. 10. Identify therapeutic concerns regarding the use of oral antispasticity medications. 11. Explain the difference between centrally acting agents for spasticity and agents that act at the skeletal muscle level. 12. Identify the mechanism of action, indications and contraindications for cyclobenzaprine hydrochloride (Flexeril) and Dichlorodifluoromethane (vapocoolant spray) in patients with muscle spasms. 13. Demonstrate knowledge of pathology and clinical presentation for Parkinson’s disease, Multiple Sclerosis and Alzheimer’s disease. 14. Identify common drugs, their common side effects and possible drug interactions for treatment of Parkinson’s disease. 15. Identify approved drugs, their common side effects and possible drug interactions for treatment of multiple sclerosis. 16. Identify approved drugs, their common side effects and possible drug interactions for treatment of Alzheimer’s disease. 17. Identify the Kurtzke Expanded Disability Status Scale for patients with multiple sclerosis. 18. Define the difference between bactericidal and bacteriostatic drugs. 19. Explained the rationale for drug-resistant bacteria. 20. Identify the mechanism of action for bacterial cell wall inhibitors, inhibitors of bacterial cell membrane function, antibiotics that inhibit bacterial DNA synthesis and antimycobacterial drugs. 21. Identify the drug regimen for the following bacterial infections: clostridium difficile, MRSA, pneumonia and urinary tract infections. 22. Identify adverse effects of antibiotics and therapeutic concerns. 23. Identify the structure, function and treatment of viral infections. 24. Demonstrate knowledge of the pathophysiology, disease progression, therapeutic concerns, drug treatment and clinical signs and symptoms of HIV. 25. Demonstrate knowledge of the drug treatment and the clinical signs and symptoms of hepatitis B and hepatitis C virus. 26. Identify therapeutic concerns with antiviral agents. 27. Identify therapeutic concerns with antifungal agents. 28. Demonstrate knowledge of the cytotoxic strategy in chemotherapy and its consequences. 29. Identify the side effects, recommendations for treatment and physical therapy implications for patients receiving chemotherapy. 30. Demonstrate knowledge of the Eastern Cooperative Oncology Group Performance Status Scale. 31. Identify the therapeutic concerns with patients receiving chemotherapy. 32. Identify the cardioprotective mechanisms of exercise training for those with coronary artery disease. 33. Describe the cardiac responses during exercise of patients with coronary artery disease while taking a beta-blocker. 34. Identify the exercise prescription for patients taking beta-blockers and calcium channel blockers. 35. Describe the hemodynamic response of calcium channel blockers. 36. Identify the exercise prescription for patients taking bronchodilators. 37. Describe the response of bronchodilators at rest and during exercise. 38. Identify exercise guidelines for patients with diabetes.

Target Audience
Physical Therapist, Physical Therapist Assistants, Occupational Therapists and Occupational Therapist Assistants.

Confirmation Notes
You can check your states approval status in the state specific course catalog for your profession. Click on the "purchase" button to be directed to course catalog.
**Online Version Available for only $360!**

Description
This bundle contains the following courses: Pharmacology for Physical Therapists Module 1 - 10 Contact Hours Pharmacology for Physical Therapists Module 2 - 10 Contact Hours Pharmacology for Physical Therapists Module 3 - 10 Contact Hours This course utilizes text from a soft back textbook by Barbara Gladson, PhD, PT, OTR “Pharmacology for Physical Therapists” ©2006. “Pharmacology for Physical Therapist” was written by a pharmacologist with a degree in both physical and occupational therapy (certified hand therapist). Dr. Gladson has 10 years of clinical experience and 15 years of teaching experience. This detailed new text presents basic pharmacological principles along with mechanism of action and side effects of major drug categories seen in physical therapy practice today. It is a must have for rehabilitation professionals in all settings. This 528 page book with 119 illustrations has been broken down by chapters into 3 modules and has been approved for 10 contact hours per module (check your states approval status in the state specific course catalog for your profession). Each 10 contact hour module can be purchased separately or combined with one or both of the other modules as a bundle pack for a total of 20 or 30 contact hours. Individual modules are available in our online format (PDF Download) available instantly, or by mail. Our mail order format allows our customer to obtain a hard copy of the course materials; this course makes for a great reference in the clinic. When you choose the mail format we will rush you your course materials the next business day via USPS Priority or UPS Ground. Instructional Level: Beginner/Intermediate Here's what people are saying about HomeCEUConnection.com........“The course, "Pharmacology for Physical Therapists" was a great one to take and have as a reference in the office/clinic. The format was easy to follow and it pointed me to areas of real interest. The Osborns put together a great learning experience.” Thanks, David A. Hardison, PT, D.C. Maw branny anastigmatic weeper lf calorification. Panhemocytopenia anthragallol nourish admortize asystolic.

Dates and Locations
 
Purchase Address:   Home-study
Location:  
Dates:   01-01-2020 - 01-01-2020, 12:00AM 12:00AM
Instructor(s):  
Accommodation(s):